Moderna at AAPS 2026 PharmSci 360

Oct 25–28, 2026 New Orleans, LA ~4k attendees Website

Moderna brings 3 presentations to AAPS 2026 PharmSci 360 in New Orleans. Its program centres on measuring mRNA medicines in the body, including validation of an RT-qPCR method for lipid nanoparticle mRNA. Its sessions also cover lipid nanoparticles and digital PCR for measuring a viral genome in human cells.

OrganizationAAPS 2026 PharmSci 360 Attendance
Moderna
Cambridge, MA
Biotech
Biotech developing and marketing mRNA medicines and vaccines, including COVID-19 and RSV vaccines.
Talk
Mon Oct 26
9:30am–10:00am
Part of Symposium: Building Regulatory Confidence in Molecular Assays
RT-qPCR for LNP-mRNA PK: Case Study of Validation Strategy, In-Study Performance
211-213
Bioanalytics
Talk
Mon Oct 26
10:30am–11:00am
Part of Symposium: Advancing Biologics Manufacturing Through Robust Process Design, Standards, and Lifecycle Management
LNP
224
Manufacturing and Analytical Characterization
Talk
Mon Oct 26
3:45pm–4:00pm
Part of Rapid Fire: Advancing Bioanalysis for Next-Generation Therapeutics
ddPCR Assay for Quantification of a Viral Genome in Human Cell Populations
211-213
Bioanalytics

Explore the full AAPS 2026 PharmSci 360 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full AAPS 2026 PharmSci 360 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Moderna

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American Association of Pharmaceutical Scientists (AAPS). Submit a correction